US EditionPublished • loading... • Updated
Bristol Myers Squibb Company $BMY Shares Sold by Tufton Capital Management
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bristol Myers Squibb Company $BMY Shares Sold by Tufton Capital Management
Tufton Capital Management reduced its holdings in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 5.9% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 73,506 shares of the biopharmaceutical company’s stock after selling 4,575 shares during the quarter. Tufton Capital Management’s holdings in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
